Brown Capital Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Brown Capital Management’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-26,969	Closed	-$1.17M	–	135
2015 Q3	$1.17M	Sell	26,969 -6,804	-20%	-$287K	0.02%	103
2015 Q2	$1.43M	Sell	33,773 -14,666	-30%	-$619K	0.02%	102
2015 Q1	$1.88M	Sell	48,439 -4,680	-9%	-$180K	0.03%	96
2014 Q4	$1.79M	Hold	53,119	–	–	0.03%	97
2014 Q3	$1.86M	Hold	53,119	–	–	0.03%	99
2014 Q2	$1.75M	Buy	53,119 +38,503	+263%	+$1.32M	0.03%	108
2014 Q1	$539K	Hold	14,616	–	–	0.01%	116
2013 Q4	$561K	Buy	+14,616	New	+$461K	0.01%	117

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Brown Capital Management's WX Position: Q4 2015 in Review

Brown Capital Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 26,969 shares — an estimated $1.17M sold.

Brown Capital Management first reported a position in WX in Q4 2013 and held it in 8 quarters. The position peaked at $1.88M in Q1 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Brown Capital Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Brown Capital Management sold 26,969 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $1.17M.
Brown Capital Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2013 and held it in 8 quarters.
Brown Capital Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $1.88M in Q1 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Brown Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.